Medical Tourism Cost vs US Procedures: Data

Key Figures at a Glance

Sources: Patients Beyond Borders (2023–2024); Best Clinic Abroad (2025); KFF/Peterson Health System Tracker NHE 2024; Medical Tourism Association Patient Survey 2024; ADA-sourced dental cost data via RealDentalCosts.com (2025). US costs reflect self-pay or high-deductible exposure, not negotiated in-network rates.

Where the Savings Are Real — and Where the Math Falls Apart

The medical tourism industry’s savings claims range from 25% to 90% depending on destination, procedure category, and which source you read. Patients Beyond Borders, the most frequently cited data aggregator in this space, pegged the 2023 market at $63–88 billion globally, with roughly 21–22 million cross-border patients spending an average of $3,510 per visit including travel and accommodation. That per-visit figure matters: it’s the denominator that gets omitted when a headline announces “save 80% on your surgery.”

Run the arithmetic on a hip replacement. Best Clinic Abroad (2025 data) prices the procedure at approximately $15,000 in Thailand and $8,000 in India at JCI-accredited facilities, against a US self-pay range of $40,000–$50,000. Gross savings: $25,000–$42,000. Add round-trip international airfare ($1,200–$2,500 depending on origin), a two-week hotel stay ($2,000–$4,000 for recovery-appropriate accommodation), local transport, and a medical escort or coordination service ($500–$1,500), and total trip costs run $3,000–$6,000 per Patients Beyond Borders’ own estimates. Net savings after travel: still $19,000–$36,000. For a household paying out-of-pocket or carrying a high out-of-pocket maximum, that number is real.

The calculus looks completely different for elective dental work. A single-tooth implant in Mexico runs approximately $1,800–$2,500 (Best Clinic Abroad, 2025). The US range for the same procedure — implant post, abutment, and crown — sits at $3,000–$6,000 per tooth according to ADA-sourced industry data compiled by RealDentalCosts (2025). Gross savings on one implant: $500–$4,200. After a round trip to Cancún or Los Alamos ($300–$600) plus hotel, the net advantage shrinks to $200–$3,600 per tooth. For a single implant, the numbers barely justify the trip. At four implants, they do.

Sources: US costs — Patients Beyond Borders; Medical Tourism Packages (2026); knee replacement range per Medical Tourism Packages (2026) and OJRCA self-pay data. Abroad costs — Best Clinic Abroad (2025); Patients Beyond Borders (2024). Trip cost range — Patients Beyond Borders average $3,510/visit (2023 data). IVF US range per Finluxy cluster data; abroad range per Best Clinic Abroad (2025). Net savings are estimates; individual results vary by destination, facility tier, and case complexity.

The Insurance Interaction Problem

Here is where the math diverges sharply based on income bracket and insurance status. A household earning $175,000 with solid employer-sponsored coverage faces a very different equation than the population that medical tourism marketing typically targets.

According to KFF’s 2024 Employer Health Benefits Survey, the average employer-sponsored single coverage plan cost $8,951 per year in 2024, with workers at large firms averaging a $1,538 deductible. For a household at that coverage tier, the out-of-pocket exposure on a knee replacement — assuming the procedure is medically necessary and in-network — may be nothing beyond the deductible and coinsurance up to the out-of-pocket maximum at higher income levels. Comparing a $30,000–$35,000 procedure to a $10,000 abroad alternative is irrelevant if the household’s actual exposure is $3,000–$6,000 through their plan.

Standard US health insurance does not cover procedures performed abroad. Most domestic plans exclude foreign medical care categorically, with narrow exceptions for emergency treatment while traveling. The CDC’s medical tourism guidance states this plainly: follow-up care for complications from foreign procedures can be expensive and is frequently uncovered by domestic insurance. That’s not a minor footnote. A patient who saves $25,000 on a hip replacement in Thailand but develops a post-surgical infection requiring $15,000 in domestic treatment has cut their net savings significantly — and that complication risk is real. A 2024 IDWeek presentation by CDC medical officer Dr. Jeremy Gold noted that data on complications is systematically underreported because there is no reliable mechanism to track them once a patient returns home.

Standard travel insurance is equally unhelpful. As UK patient safety organization PHIN documents, standard travel policies explicitly exclude planned medical procedures and their complications. Purpose-built medical tourism insurance exists but adds meaningful cost. For the $150k+ household already paying premium insurance rates, this creates a coverage gap that doesn’t exist domestically.

Where JCI Accreditation Actually Matters

The Joint Commission International (JCI) accreditation is the international benchmark most cited in medical tourism discussions. More than 950 hospitals worldwide hold JCI accreditation, with the number growing approximately 20% annually per Patients Beyond Borders. JCI evaluates patient safety, care delivery, surgical protocols, infection control, and staff qualifications — the same standards framework used domestically by the Joint Commission.

Restricting consideration to JCI-accredited facilities is not optional for this population. The comfort of knowing a surgeon trained at a European or US institution works at a non-accredited Thai clinic is not a substitute for independent quality verification. Bumrungrad International Hospital in Bangkok, Apollo Hospitals and Fortis Healthcare in India, and Pablo Tobón Uribe in Medellín are among the repeatedly cited JCI-accredited institutions. The cost premium for JCI-accredited facilities over non-accredited alternatives varies, but the gap should be treated as mandatory spend, not optional.

Even within the JCI tier, procedure-specific outcomes data is thin. The executive health program infrastructure in the US maintains longitudinal records that most destination hospitals serving international patients simply do not provide in a format accessible to domestic follow-up physicians. For complex cardiac cases or orthopedic revisions — procedures where follow-up imaging and outcome tracking matter — that data continuity gap carries genuine clinical risk that no accreditation badge resolves.

Finluxy Healthcare Spend Index: Modeling the Medical Tourism Decision

The Finluxy Healthcare Spend Index measures household annual out-of-pocket healthcare spend (excluding premiums) as a percentage of gross household income. The KFF benchmark for $150k+ households runs 1.2–2.5% of gross income. Medical tourism becomes materially relevant when a single procedure would push a household significantly above that range for the year.

Finluxy Healthcare Spend Index = Annual OOP spend ÷ gross household income × 100. KFF benchmark for $150k+ households: 1.2–2.5%. US OOP figures based on self-pay or HDHP exposure per Patients Beyond Borders (2025) and industry data. Abroad OOP = procedure cost + $3,000–$6,000 trip costs per Patients Beyond Borders average. In-network scenario uses KFF 2024 Employer Health Benefits Survey deductible and OOP max data. These are illustrative models, not guarantees of individual cost outcomes.

The table reveals the core insight: medical tourism dramatically improves the Finluxy Healthcare Spend Index for self-pay and high-deductible households but often worsens it for households with strong employer coverage. A $200,000-income household with a low-deductible employer plan is already inside the KFF benchmark at 1.5%–3.0% for a hip replacement. Going abroad takes that Index to 5.5%–10.5% once travel costs are included — a worse outcome by definition, before accounting for the insurance coverage gap and complication risk.

The HSA Optimization Angle

For households structured around a high-deductible health plan (HDHP), the health savings account (HSA) changes the medical tourism calculus in one specific way: HSA-eligible plan structures mean the self-pay exposure that makes medical tourism attractive can be partially offset through pre-tax dollars. The 2025 HSA contribution limits per IRS Publication 969 are $4,300 for self-only coverage and $8,550 for family coverage, rising to $4,400 and $8,750 respectively in 2026. Individuals 55 and older can contribute an additional $1,000.

A household maxing family HSA contributions at $8,550 in 2025 captures federal, state (where applicable), and FICA tax savings that effectively reduce the real cost of any domestic or foreign medical spending paid from the account. At a combined marginal rate of 37% federal plus state, the tax shield on $8,550 approaches $3,100–$4,000 annually. That doesn’t eliminate the gap between domestic and foreign procedure costs — but it means a household running a well-structured HDHP paired with a direct primary care (DPC) membership has lower effective out-of-pocket exposure than raw sticker prices suggest.

What the HSA does not do is make insurance cover foreign procedures. Any medical tourism spending paid from an HSA is still qualified medical expense spending — tax-free — but the underlying insurance exclusion on foreign procedures remains. The premium healthcare cost structure for this income bracket has to be evaluated as a whole system, not procedure by procedure.

The Overlooked Variable: Complication Remediation Cost

Most medical tourism cost comparisons stop at the procedure price differential. The figure most coverage overlooks is the expected value of complication remediation — the cost of treating complications domestically after a foreign procedure, weighted by complication probability.

The CDC’s 2024 IDWeek data noted that infection is the most frequently documented complication in medical tourism cases, particularly for cosmetic and bariatric surgeries. Documented outbreaks have included carbapenem-resistant Pseudomonas aeruginosa linked to bariatric surgery in Tijuana in 2018–2019, and nontuberculous mycobacteria infections from plastic surgery in the Dominican Republic in 2017. These are not fringe cases. They are documented, named outbreaks with identifiable patients. The CDC’s Dr. Gold acknowledged explicitly at IDWeek 2024 that reliable complication tracking does not exist — which means the figures that do exist almost certainly undercount the true rate.

For a $150k+ household, the remediation cost problem is compounded by the insurance exclusion. If a domestic insurer denies coverage for complications arising from a foreign procedure — which is permitted under standard policy language — the household absorbs the full cost of any domestic follow-up care. A week of inpatient hospital care for surgical infection in the US regularly exceeds $15,000–$30,000. The 2024 MTA Patient Survey reported that hidden costs and complication concerns were the top two factors that discouraged Americans from pursuing medical tourism. That survey response reflects rational risk assessment, not timidity.

Destination-Specific Data: Where the Numbers Hold Up

Not all destination cost data is equally reliable. Best Clinic Abroad’s 2025 destination comparison, drawing on Patients Beyond Borders data and OECD Health Statistics (2024), presents the most granular figures available by procedure and country tier.

Sources: Best Clinic Abroad (2025), citing Patients Beyond Borders and OECD Health Statistics (2024); Medical Tourism Packages (2026); A-Medical clinic data via amedical.az (2026). Figures are estimates for JCI-accredited or equivalent-tier facilities. Colombia hip replacement range per Medical Tourism Packages (2026). Turkey LASIK per Best Clinic Abroad (2025). All figures are procedure plus standard hospital stay; excludes flights, hotel, and ancillary costs. Currency fluctuation and facility-tier variation can shift figures meaningfully.

India’s advantage is most pronounced in cardiac surgery, where it offers by far the lowest absolute price for complex procedures. The savings are large enough — $73,000–$123,000 gross on a bypass — that even a conservative estimate of complication risk and trip costs leaves a substantial net benefit for self-pay patients. Mexico’s proximity advantage is most relevant for dental procedures, where travel time and cost are minimized. For a household in the Southwest or Southeast, a dental plan’s annual coverage cap can often be supplemented cost-effectively with a cross-border dental trip for multi-implant work.

The $150k+ Household Decision Framework

The data points to a clear threshold logic. Medical tourism is financially compelling when: (1) the procedure is elective or semi-elective, not time-critical; (2) the household’s domestic insurance does not meaningfully cover the procedure; (3) the gross cost differential exceeds $15,000 after estimated trip costs — roughly the point at which the Finluxy Healthcare Spend Index improvement is large enough to absorb worst-case complication remediation scenarios; and (4) the destination facility holds JCI accreditation.

The model breaks down when any of those four conditions fails. Cardiac procedures at top-tier Indian hospitals meet all four criteria for a self-employed, uninsured household at $150k income — the Index improvement is catastrophic without medical tourism (53%+) and compelling with it (7%–17%). That same household considering a single dental implant does not meet condition 3: the gross differential after a Mexico trip is unlikely to exceed $2,000–$3,000, which is inadequate cushion against even minor complications.

What the data does not support is the category of decision often marketed to this income bracket: traveling abroad for procedures that good concierge medicine or strong employer coverage would cover at low out-of-pocket cost. A household paying $3,000–$6,000 domestically for a covered knee replacement — well within the KFF benchmark range — gains nothing by substituting a $13,000–$19,600 abroad trip that includes travel costs and insurance exposure. The annual healthcare spend benchmark for this income tier rewards plan optimization first, procedure arbitrage second.

For the household that is genuinely self-pay — self-employed, between jobs, or carrying a catastrophic-only HDHP — medical tourism for major orthopedic or cardiac procedures belongs in the financial planning conversation alongside long-term care insurance cost modeling and mental health coverage gaps. The numbers are large enough, and the Finluxy Healthcare Spend Index movement significant enough, that ignoring the option is itself a financial decision. The risk-adjusted math, however, requires honest accounting of complication probability, domestic remediation cost, and the insurance gap — not just the procedure price differential the industry leads with.